Eric Simone, Ph.D.

Eric brings extensive industry experience working at the interface of development with research, clinical and commercial development in Oncology, Antivirals and Rare Genetic Diseases. Prior to joining Ensem Therapeutics, Eric was the Senior Director of Formulation Development and Manufacturing at Agios Pharmaceuticals. Eric and his team focused on novel platforms and rapidly enabling formulations for poor solubility and low permeability therapeutics for multiple oncology and hemolytic anemia programs. Before Agios, Eric worked at Vertex Pharmaceuticals focusing on small molecules for HCV, influenza and Cystic Fibrosis, along with building out their continuous manufacturing initiative. In addition to leading several CMC Tech Teams, Eric was a central part of a virtual “FluDev” team, running all CMC and supply chain aspects of a Ph2b clinical study spanning seven countries and over 200 clinical sites.

Eric trained at Johns Hopkins University and the University of Pennsylvania for his B.S. and Ph.D. respectively in biomedical engineering. He was a post-doctoral fellow in Radiology at the Hospital of the University of Pennsylvania.